SCHEMBL29016222

SCHEMBL29016222

CNS(=O)(=O)c1ccc2c(c1)C(=Cc1[nH]cc(C(=O)OC)c1C)C(=O)N2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 3/20 0.58
▸ KDR P35968 10/20 0.57
▸ AKT2 P31751 1/20 0.53
▸ SRC P12931 10/20 0.53
▸ FGFR1 P11362 7/20 0.52
▸ PDGFRB P09619 6/20 0.52
▸ AURKA O14965 2/20 0.50
▸ LCK P06239 6/20 0.49
▸ FYN P06241 6/20 0.49
▸ YES1 P07947 6/20 0.49
▸ NTRK1 P04629 1/20 0.49
▸ FCER2 P06734 1/20 0.49
▸ SYK P43405 1/20 0.49
▸ NTRK3 Q16288 1/20 0.49
▸ NTRK2 Q16620 1/20 0.49
▸ KIT P10721 1/20 0.47
▸ PDGFRA P16234 1/20 0.47
▸ FLT4 P35916 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ AURKB Q96GD4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452506 0.96 CDK2 (0.55) CDK2KDRAKT2SRCFGFR1
SCHEMBL2115487 0.90 AKT2 (0.65) CDK2KDRAKT2SRCFGFR1
SCHEMBL2115490 0.90 AKT2 (0.65) CDK2KDRAKT2SRCFGFR1
SCHEMBL2117358 0.84 KDR (0.55) CDK2KDRAKT2SRCFGFR1
SCHEMBL31672436 0.84 KDR (0.55) CDK2KDRAKT2SRCFGFR1
SCHEMBL2117364 0.84 KDR (0.55) CDK2KDRAKT2SRCFGFR1
SCHEMBL2114522 0.84 CDK2 (0.56) CDK2KDRAKT2SRCFGFR1
SCHEMBL2114520 0.84 CDK2 (0.56) CDK2KDRAKT2SRCFGFR1
SCHEMBL2118199 0.83 CDK2 (0.51) CDK2KDRAKT2SRCFGFR1
SCHEMBL2118195 0.83 CDK2 (0.51) CDK2KDRAKT2SRCFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 — — CN disclosed
Send feedback